Becker's Oncology

Beginning in April, Boston-based Brigham and Women’s Hospital will phase out all currently contracted Dana-Farber Cancer Institute physician assistants by the end of 2026, according to a Feb. 12 Boston Globe report.  Dana-Farber, also based in Boston, is ending its…

New prostate cancer diagnoses increased 12.08% and prostate-specific antigen screenings increased 52.18% between 2021 and 2024, according to data published Feb. 12 by Epic Research.  Epic’s research division utilized data from Cosmos, a dataset created in collaboration with a community…

Patients with endometrial hyperplasia or benign uterine pathology had a 66% reduced risk of developing endometrial cancer when treated with progestins and a GLP-1 compared to patients treated with progestins alone, according to a study published Feb. 10 in JAMA…

In November, Peoria, Ill.-based OSF HealthCare named James McGee, MD, president of the system’s cancer institute. Dr. McGee grew up on a small farm in central Illinois, where limited access to care shaped his early understanding of rural healthcare gaps.…

We have entered a decisive era for U.S. cancer care. Seventy percent of people now live at least five years after a cancer diagnosis, an unprecedented milestone founded on decades of scientific research. Yet these gains are not shared equally…

In a move that underscores Duarte, Calif.-based City of Hope’s mission to translate scientific discovery into real-world outcomes, the organization recently appointed Vanessa Almendro Navarro, PhD, as chief commercialization officer.  In her role, Dr. Almendro Navarro is at the helm…

The Surgical Review Corporation has named Newport Beach, Calif.-based Hoag the world’s first center of excellence in oncoplastic breast surgery. In a Feb. 11 news release, Nirav Savalia, MD, medical director of oncoplastic and aesthetic breast surgery at Hoag, said…

In April, Bend, Ore.-based St. Charles Health System will open a cancer center in Redmond, Ore., that can serve up to 300 patients per day.  The facility will be nine times larger than the system’s current cancer care facilities in…

Orange, Calif.-based UCI Health has expanded the inpatient bed capacity of its stem-cell transplant program by 200% after opening the UCI Health — Irvine (Calif.) medical campus in December.  The inpatient suites are designed to facilitate customized cell therapy delivery…

Salt Lake City-based Huntsman Cancer Institute at the University of Utah will be the first U.S. academic medical center to manufacture a novel prostate cancer imaging drug, flotufolastat F 18. The drug was developed by Blue Earth Diagnostics and will…